Jade Biosciences, Inc. Common Stock JBIO Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $88.44M+27.5% | $69.39M+195% | $23.49M+4.9% | $22.4M-58.6% | ||
| $247.72M— | $0-100% | $98.95M-7.4% | $106.82M-5.6% | ||
| $18.32M+45.3% | $12.61M+53.5% | $8.21M-26.2% | $11.13M+9.1% | ||
| $348.82M+401% | $69.65M-43.9% | $124.23M-5.5% | $131.5M-24.6% | ||
| $170K— | $0-100% | $288K+19.0% | $242K+30.1% | ||
| $726K— | $0-100% | $614K-38.8% | $1M+85.1% | ||
| $69K-97.8% | $3.15M+37.7% | $2.28M-10.8% | $2.56M+748% | ||
| $349.78M+380% | $72.8M-42.9% | $127.42M-5.8% | $135.3M-22.8% | ||
| $2.15M+66.7% | $1.29M-46.2% | $2.4M-7.0% | $2.58M+113% | ||
| $16.54M+37.9% | $12M-32.0% | $17.64M+127% | $7.78M+205% | ||
| $724K— | $0-100% | $255K-63.8% | $705K+84.6% | ||
| $851K+104% | $417K-38.2% | $675K-38.1% | $1.09M+89.9% | ||
| $17.26M-85.6% | $119.6M+566% | $17.96M+110% | $8.56M+191% | ||
| —— | —— | —— | —— | ||
| $5K+400% | $1K-66.7% | $3K+50.0% | $2K0.0% | ||
| $506.77M+283,012% | $179K-99.9% | $272.64M+26.7% | $215.11M+3.0% | ||
| -$174.39M-271% | -$46.98M+71.3% | -$163.42M-85.9% | -$87.9M-142% | ||
| $129K— | $0-100% | $237K+151% | -$466K-690% | ||
| $332.52M+811% | -$46.8M-143% | $109.46M-13.6% | $126.74M-26.5% | ||
| $349.78M+380% | $72.8M-42.9% | $127.42M-5.8% | $135.3M-22.8% | ||
| $69K-97.8% | $3.15M+37.7% | $2.28M-10.8% | $2.56M+316% | ||
| $726K— | $0-100% | $614K-38.8% | $1M+85.1% | ||
| $726K— | $0-100% | $614K-38.8% | $1M+85.1% | ||
| $69K-97.8% | $3.15M+37.7% | $2.28M-10.8% | $2.56M+748% | ||
| $247.72M— | $0-100% | $98.95M-7.4% | $106.82M-5.6% | ||
| $726K— | $0-100% | $614K-38.8% | $1M+85.1% | ||
| $69K-97.8% | $3.15M+37.7% | $2.28M-10.8% | $2.56M+748% | ||
| $9.42M+128% | $4.13M— | —— | —— | ||
| $4.97M-9.7% | $5.5M— | —— | —— | ||
| $0-100% | $1.08M— | —— | —— | ||
| $0-100% | $107.6M— | —— | —— | ||
| $851K+104% | $417K-38.2% | $675K-38.1% | $1.09M+89.9% | ||
| $5K+400% | $1K-66.7% | $3K+50.0% | $2K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Jade Biosciences, Inc. Common Stock's total assets?
- Jade Biosciences, Inc. Common Stock (JBIO) holds $319.4M in total assets, up 312.0% year over year.
- How much debt does Jade Biosciences, Inc. Common Stock have?
- Jade Biosciences, Inc. Common Stock carries $808.0K in total debt against $296.5M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Jade Biosciences, Inc. Common Stock have?
- Jade Biosciences, Inc. Common Stock holds $55.1M in cash and equivalents.
- Can Jade Biosciences, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 14.29 — current assets exceed current liabilities.
- Where does Jade Biosciences, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Jade Biosciences, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.